GoodRx appoints Justin Fengler as CFO, replacing Christopher McGinnis

GoodRx Holdings, Inc.

Christopher McGinnis to step down as CFO & Treasurer effective Aug 5, 2026; departure not due to disagreement.
Justin Fengler, current Chief Strategy & Operations Officer, appointed CFO & Treasurer effective Aug 6, 2026.
Fengler receives $600k RSU, $600k PSU, $100k cash, and Tier 1 severance plan designation.
McGinnis expected to receive severance per Tier 1 plan and sign separation agreement with non-disparagement.
Fengler has been with GoodRx since 2016, previously SVP of Corporate Strategy & Business Operations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.